Medigus Ltd Sponsored

Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Viewbix is a subsidary of Gix Internet whose results consolidated with Medigus‘ financial

Medigus: Viewbix Reports Record Revenues of $66 million in the First Nine Months of 2022 Representing Increase of 176%

The Company will provide an update regarding the distribution date

Medigus Announces Cash Capital Distribution of $1.6 Million

The purchase order amounts to approximately $2 41 ,000 USD

Medigus: An International Aerospace Company has Purchased Dozens of ParaZero's SafeAir Safety Systems

The letter of intent was signed with a Tel-Aviv Stock Exchange listed company to hold 74.99% of the merged company

Medigus: Eventer Technologies Signed a Letter of Intent for Spin-Off and an approx. $13 million Reverse Merger

Revenues for the first nine months of 2022 were approx. $1.99 million

Medigus: Eventer Generated Record Revenues for the First Nine Months of 2022 Exceeding Full-Year 2021 Revenues

Using its advanced technology, Jeffs' Brands evaluated new lucrative products and now offers them in its stores

Medigus: Jeffs' Brands Reinforces its Brands for the Holiday Season with Potential High Profitability Products

Tel Aviv, Israel, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that Jeffs' Brands Ltd. ("Jeffs' Brands" owned 35.27% by Medigus), a data-driven E-commerce company operating on the Amazon Marketplace, has taking steps to support its growth and expansion.

Medigus: Jeffs' Brands to Expand Sales Beyond Amazon.com into New Leading E-commerce Platforms

Tel Aviv, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it plans to effect 1:15 ratio change of the Company's American Depositary Receipt, or ADR, program. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from one (1) ordinary share to fifteen (15) ordinary shares. The effective date anticipated for the ratio change is November 14, 2022 and the Company's ADSs will continue to be traded on the Nasdaq Capital Market under the symbol “MDGS” with a new CUSIP Number 58471G 409.

Medigus Announces Plan to Implement ADS Ratio Change

Tel Aviv, Israel, Oct. 21, 2022 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that Jeffs' Brands Ltd. ("Jeffs' Brands"), a data-driven e-commerce company operating on the Amazon Marketplace, announced that it has entered into a non-binding letter of intent for the purchase of an Amazon Marketplace brand ("the brand") for $2.5 million in cash.

Medigus: Jeffs' Brands entered into Non-Binding Letter of Intent to Acquire an Amazon Marketplace Leading Supplements Brand with Annualized Revenues of Approximately $2.7 million in 2022

Tel Aviv, Israel, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that ScoutCam Inc. (OTCQB: SCTC) (“ScoutCam”, owned 27.02% by Medigus), a leading provider of visualization and AI based solutions to the Condition Based Monitoring (CBM) and the Predictive Maintenance (PdM) markets, announced the appointment of Yehu Ofer as chief executive officer, effective immediately. Mr. Ofer, a former Israeli Air Force (IAF) pilot and commander, as well as a leading professional in the aviation and aerospace industries, will lend his decades of experience to ScoutCam's continued growth and success. Scoutcam develops and manufactures video sensor-based solutions for critical systems in aviation, space, transportation, and energy markets, and enhances its capabilities and unique solutions across major verticals of Industry 4.0.

Medigus: ScoutCam Announces Appointment of Yehu Ofer as Chief Executive Officer

Athersys

Evaxion Biotech A/S

High volume penny stocks to watch before next week. The post Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today

Record Revenues of $34.95 million, up over 1,300% Y-o-Y Record Revenues of $34.95 million, up over 1,300% Y-o-Y

Medigus Announces Record 2022 First Half Financial Results

Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd. ("Polyrizon"), a privately held company in which Medigus owns 37.03%, has submitted a PCT (Patent Cooperation Treaty) application, following a submission to the United States Patent and Trademark Office for its innovative technology.

Medigus: Polyrizon Submitted an International Patent Application for its Platform Technologies

Tel Aviv, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution  up to of $1.6 million.

Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution

Eventer's turnover from tickets sales for the first half of 2022 amounted to approx. $35 million an increase of approx. 307% compared to the first half of 2021

Medigus: Eventer Achieved Record Revenues increase of 211% Year-Over-Year to Approximately $1.4 Million in The First Half of 2022

As a result of the closing, Medigus now owns 35.27% of Jeffs' Brands

Medigus: Jeffs' Brands Ltd. Announces Closing of $15.5 Million Initial Public Offering

Medigus' financials results for the first half of 2022 will include, for the first time, the consolidation of Gix Internet‘s financials

Medigus: Gix Internet Reports Revenues Increase of 166% Year-over-Year to Approximately $43.4 Million in the First Half of 2022

Tel Aviv, Israel, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that Jeffs' Brands Ltd. ("Jeffs' Brands"), a data-driven e-commerce company operating on the Amazon Marketplace, announced on August 25, 2022, the pricing of its initial public offering of 3,717,473 units. Each unit is being offered at a public offering price per unit of $4.16 and consists of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $4.04 per share. The gross proceeds of the offering are expected to be approximately $15.5 million before deducting underwriting discounts and other estimated offering expenses. The offering is expected to close on Tuesday, August 30, 2022, subject to satisfaction of customary closing conditions.

Medigus: Jeffs' Brands Ltd. Announces Pricing of $15.5 Million Initial Public Offering

Polyrizon Ltd, in which Medigus Ltd (NASDAQ: MDGS) owns a 37.03% stake, signed a binding Collaboration Agreement with NurExone Biologic Inc for therapies for traumatic spinal cord injuries. Polyrizon is an Israeli biotech company specializing in intranasal.

Medigus' Polyrizon Inks Agreement To Develop Therapies For Traumatic Spinal Cord Injuries

Tel Aviv, Israel, July 05, 2022 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that ParaZero Technologies Ltd. ("ParaZero"), a leading provider of autonomous drone safety systems for commercial drones and urban air mobility (UAM) aircraft, of which Medigus has a 40 percent ownership stake, has signed a non-binding memorandum of understanding (MoU) with Bon V, a leading Indian aerospace manufacturer, to integrate ParaZero SafeAir parachute recovery systems with Bon V's products.

Medigus: ParaZero Signed a Non - Binding MOU to Provide Autonomous Safety Systems for Bon V Heavy Lift Cargo Drones

Tel Aviv, Israel, June 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that ScoutCam Inc. (OTCQB: SCTC) (“ScoutCam”, owned 27% by Medigus), a leading provider of visualization and AI based solutions to the Condition Based Monitoring (CBM) and the Predictive Maintenance (PdM) markets, announced today a Joint Development Agreement (JDA) with a global leading defense and aviation company.

Medigus: ScoutCam Signs a Joint Development Agreement to Equip Aerial Platforms of a Top Global Defense and Aviation Manufacturer with In-Flight Monitoring Solutions

Tel Aviv, Israel, June 17, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it has received a notification letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company's American Depositary Shares (“ADSs”) has closed below a minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company's ADSs, and its ADSs will continue to trade on The Nasdaq Capital Market under the symbol “MDGS” at this time.

Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Record Revenues of $10.1 million, up 1 ,805 % over 2020 47% gross margin and 40% net margin $4 million net income for the full year, up from a net loss of $6.9 million in 2020

Medigus Announces Record Fiscal Year 2021 Financial Results

New investment targets improving and optimizing the global water, oil, and gas transportation infrastructure through cutting-edge technology that reduces pump energy requirements New investment targets improving and optimizing the global water, oil, and gas transportation infrastructure through cutting-edge technology that reduces pump energy requirements

Medigus to Invest in a Deep Energy Tech Company

The results are consistent with a series of Polyrizon's previous successful tests in human coronavirus 229E and Influenza Virus H1N1 The results are consistent with a series of Polyrizon's previous successful tests in human coronavirus 229E and Influenza Virus H1N1

News for Medigus Ltd Sponsored Stock (MDGS)